Stay updated on Nebulized RNS60 for ALS Clinical Trial
Sign up to get notified when there's something new on the Nebulized RNS60 for ALS Clinical Trial page.

Latest updates to the Nebulized RNS60 for ALS Clinical Trial page
- CheckyesterdayChange DetectedThe webpage has added important information regarding a clinical trial for nebulized RNS60 aimed at treating Amyotrophic Lateral Sclerosis, including details about the sponsor, Revalesio Corporation, and the trial's ClinicalTrials.gov ID.SummaryDifference25%
- Check8 days agoChange DetectedThe webpage has removed significant information regarding a clinical trial for nebulized RNS60 for the treatment of Amyotrophic Lateral Sclerosis, including details about the sponsor and the study's recruitment status.SummaryDifference20%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has been updated to version 2.15.0 from version 2.14.4, indicating a revision in the content. The phrase 'Here’s how you know' has been modified to 'Here's how you know', which does not significantly alter the core content.SummaryDifference1.0%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
Stay in the know with updates to Nebulized RNS60 for ALS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nebulized RNS60 for ALS Clinical Trial page.